TMRW Life Sciences

About

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

New York,New York,United States
101 - 250
https://www.tmrw.org

Highlights

Details

Last Funding Type: Funding Round
Industries: Biotechnology,Health Care,Life Science,Software
Founded date: Jan 1, 2018
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: TMRW Life Sciences, Inc.

TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics.

TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$153.50M

TMRW Life Sciences has raised a total of $153.50M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2022 from a Funding Round round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 1, 2022	Funding Round	—	1	Amy Schumer	—	Detail
Jul 21, 2021	Debt Financing	—	—	—	—	Detail
Jul 20, 2021	Series C	$105M	10	Transformation Capital	—	Detail
Dec 17, 2019	Series B	$36.50M	1	5AM Ventures	—	Detail
May 29, 2019	Series A	$12M	1	Special Situations Life Sciences Innovation Fund	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

11

TMRW Life Sciences is funded by 11 investors. Amy Schumer and Transformation Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Amy Schumer	Yes	Funding Round
Transformation Capital	Yes	Series C
5AM Ventures	—	Series C
Anne Wojcicki	—	Series C
Casdin Capital	—	Series C
GV	—	Series C
Peter Thiel	—	Series C
Presight Capital	—	Series C
Special Situations Life Sciences Innovation Fund	—	Series C
Susan Wojcicki	—	Series C